New Key Statistics Module, Z-Score and F-Score
OTCPK:AFTPF Key Ratios
| Market Cap $ M | 205.17 |
| Enterprise Value $ M | -- |
| P/E(ttm) | 28.25 |
| PE Ratio without NRI | 28.25 |
| Forward PE Ratio | 17.24 |
| Price/Book | 4.13 |
| Price/Sales | 1.76 |
| Price/Free Cash Flow | 76.58 |
| Price/Owner Earnings | 46.19 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.25 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 4.70 |
| EV-to-EBIT | 17.18 |
| EV-to-EBITDA | 15.53 |
| PEG | -- |
| Shares Outstanding M | 104.87 |
| Net Margin (%) | 6.36 |
| Operating Margin % | 9.34 |
| Pre-tax Margin (%) | 9.03 |
| Quick Ratio | 0.84 |
| Current Ratio | 1.97 |
| ROA % (ttm) | 7.63 |
| ROE % (ttm) | 16.08 |
| ROIC % (ttm) | 10.34 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.31 |
AFTPF Number of Guru Trades
AFTPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:AFTPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AFTPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AFT Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:AFTPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers